1st Quarter - Report

GREATER NEW YORK HOSPITAL ASSOCIATION for GREATER NEW YORK HOSPITAL ASSOCIATION

Firm
Client
Income
—
Expenses
$630,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —
SETH DEAN WARSHAW —

Contacted: White House Office; Defense, Dept of (DOD); Federal Bureau of Investigation (FBI); SENATE; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); President of the U.S.; Federal Emergency Management Agency (FEMA); Small Business Administration (SBA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Substance Abuse & Mental Health Services Administration (SAMHSA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA)

Health Issues HCR

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts.

Contacted: Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Substance Abuse & Mental Health Services Administration (SAMHSA); Executive Office of the President (EOP); Food & Drug Administration (FDA); Congressional Budget Office (CBO); Office of Management & Budget (OMB); SENATE; President of the U.S.; Defense, Dept of (DOD); White House Office; Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Federal Bureau of Investigation (FBI); Small Business Administration (SBA); Federal Emergency Management Agency (FEMA)

Bills named: S. 2439 (116th), H.R. 748 (116th), S. 1895 (116th), H.R. 3630 (116th), S. 2543 (116th), H.R. 1763 (116th), H.R. 3414 (116th), S. 348 (116th), H.R. 5826 (116th), H.R. 3 (116th), H.R. 3502 (116th), H.R. 6201 (116th)

Medicare/Medicaid MMM

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff.

Contacted: Health & Human Services, Dept of (HHS); Federal Emergency Management Agency (FEMA); Federal Bureau of Investigation (FBI); Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); White House Office; President of the U.S.; Office of Management & Budget (OMB); Substance Abuse & Mental Health Services Administration (SAMHSA); Health Resources & Services Administration (HRSA); Small Business Administration (SBA); Food & Drug Administration (FDA); Defense, Dept of (DOD); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 348 (116th), S. 2439 (116th), S. 2543 (116th), H.R. 748 (116th), H.R. 3414 (116th), H.R. 1763 (116th), H.R. 6201 (116th), H.R. 3 (116th)

Budget/Appropriations BUD

Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439), and its inclusion in appropriations legislative.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —
SETH DEAN WARSHAW —

Contacted: Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Federal Bureau of Investigation (FBI); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Small Business Administration (SBA); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); SENATE; President of the U.S.; Federal Emergency Management Agency (FEMA); White House Office; Office of Management & Budget (OMB); Defense, Dept of (DOD)

Bills named: S. 348 (116th), H.R. 6201 (116th), H.R. 3414 (116th), H.R. 748 (116th), H.R. 1763 (116th), S. 2439 (116th)

Pharmacy PHA

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support). Discuss the METRIC Act (H.R. 2296) with Congressional staff. Discuss legislation to address drug shortages with Congressional staff and members, the MEDS Act (S. 2373) (support), advocate for its inclusion in the CARES Act (H.R. 748). Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
LEE H PERLMAN —
KENNETH E RASKE —
DAVID C RICH —
AISLING WARDE ZACCARELLI —
SETH DEAN WARSHAW —

Contacted: White House Office; President of the U.S.; Health & Human Services, Dept of (HHS); Federal Bureau of Investigation (FBI); Substance Abuse & Mental Health Services Administration (SAMHSA); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA); Small Business Administration (SBA); Health Resources & Services Administration (HRSA); Defense, Dept of (DOD); Federal Emergency Management Agency (FEMA); Office of Management & Budget (OMB); SENATE; Medicare Payment Advisory Commission (MedPAC)

Bills named: H.R. 748 (116th), S. 340 (116th), H.R. 1506 (116th), H.R. 985 (116th), H.R. 3 (116th), H.R. 2296 (116th), S. 2373 (116th), H.R. 1503 (116th), H.R. 1520 (116th), S. 2543 (116th), H.R. 1499 (116th), H.R. 965 (116th), H.R. 938 (116th)

Affiliated organisations

OrganisationLocation
ACURITY, INC. New York, NY, US
GNYHA MANAGEMENT CORPORATION New York, NY, US
GNYHA VENTURES, INC. New York, NY, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.